drugset / Trial / NCT00576862
Extension to Study HMR1964A/3011 in Belgium
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to allow patients to continue on HOE 901 until launch and to gather additional long-term safety data.
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2004-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | — | — |